Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02584088 · ClinicalTrials.gov registry record
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
A clinical trial of Menorrhagia, sponsored by TriHealth.
- Completed
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT02584088: Completed study of Menorrhagia, sponsored by TriHealth.
NCT02584088 is a study of Menorrhagia that has completed, run by TriHealth. The registered enrollment target is 80 participants, below the 221-participant average among 10 other Menorrhagia trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02584088, a study of Menorrhagia, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
* The study primarily aims to evaluate the post ablative endometrium and uterus using transvaginal ultrasound to provide descriptive information as to what may be expected in the 12 months after a NovaSure ablation. Investigators believe this knowledge will help them to determine when to proceed with further evaluation postoperatively or when to counsel patients on expectant management based on ultrasonographic findings. * Secondary aims include correlation of ultrasonographic findings to demographic patient data.
Conditions Studied
Interventions
- OTHER Ultrasound
Study Locations (2)
Ohio
- Good Samaritan Hospital - Cincinnati
- Bethesda North Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-10-11 |
| Est. Completion | 2021-11 |
What the finished NCT02584088 record still lists
NCT02584088 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 221-participant average among 10 other Menorrhagia trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Menorrhagia appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT02584088 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02584088 about?
NCT02584088 is a clinical study titled "Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation". * The study primarily aims to evaluate the post ablative endometrium and uterus using transvaginal ultrasound to provide descriptive information as to what may be expected in the 12 months after a NovaSure ablation. Investigators believe this knowledge will help them to determine when to proceed wit...
What is the current status of trial NCT02584088?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-10-11. Estimated completion is 2021-11.
What conditions does trial NCT02584088 study?
This clinical trial studies the following conditions: Menorrhagia.
What interventions are being tested in trial NCT02584088?
The interventions under investigation include: Ultrasound (OTHER).
Who is sponsoring clinical trial NCT02584088?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02584088 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02584088's enrollment target sits among peer trials
80 10th of 10 higher than 1 of 10 other Menorrhagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menorrhagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
RECRUITING
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
COMPLETED · NA
-
Efficacy and Safety Study of XP12B in Women With Menorrhagia
COMPLETED · Phase 3
-
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
COMPLETED · Phase 3
-
Hysteroscopic Assessment of Fallopian Tubal Patency
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI